Global Radiopharmaceuticals Market Segments Overview, Latest Trends, Regions and Major Driving Forces

 Global Radiopharmaceuticals Market: Information by Type (Diagnostic (SPECT Radiopharmaceuticals, PET Radiopharmaceuticals) and Therapeutic), Application (Neurology, Cardiology, Oncology and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025

Global Market - Overview

Global Radiopharmaceuticals Market is expected to register a CAGR of 8.10% during the forecast period, with a market value of USD 15,060.87 Million till 2025.

Radiopharmaceuticals are radioactive compounds or nuclear medicines that find diagnostic and therapeutic applications in the medical industry. The radioactive particles are used in medical imaging to diagnose diseases and to treat cancer through targeted therapy.

The global radiopharmaceutical market is expected to exhibit an exponential growth during the forecast period, owing to the increasing prevalence of chronic diseases such as cancer, the growing use of radioisotopes in the healthcare industry, increasing application of radiopharmaceuticals for the diagnosis & treatment of chronic diseases, and the technological advancements in diagnostics sector.

However, factors such as the short half-life of radiopharmaceuticals and its high cost are likely to restrain the market growth. Other factors restraining the market growth are side-effects of radiopharmaceuticals and strict regulations pertaining to their manufacturing.

Key Findings of the Study

  • The Global Radiopharmaceuticals Market is estimated to grow at USD 15,060.87 million by 2025 at a CAGR of 8.10% during the assessment period.
  • Americas accounted for the largest share of the global market due to the presence of key market players and the rising demand for non-invasive diagnostics and treatments.
  • Based on the type, the diagnostics segment accounted for the largest market share of 82.9% in 2018.
  • Global radiopharmaceuticals market on the basis of application is dominated by neurology segment with 37.8% market share.

Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/1650

Segment Analysis

The Global Radiopharmaceuticals Market, by type, has been divided into diagnostics, and therapeutic. The diagnostics segment is further segmented into SPECT radiopharmaceuticals and PET radiopharmaceuticals. SPECT radiopharmaceuticals are classified into Tc99m, I-123, and Others. PET radiopharmaceuticals segment is bifurcated into F18, C11 Choline, and Others. The radioactive tracer (radiopharmaceutical) is given to the patient by intravenous injection, orally, or by other routes depending on the organ and the function to be studied. In developed countries about one in 50 persons are found to undergo diagnosis using radiopharmaceuticals each year. The growing importance of diagnostic radiopharmaceuticals to predict the effects of surgery and assess the changes is anticipated to drive the growth of this segment during the forecast period.

The Global Radiopharmaceuticals Market, by application segment, has been segmented into neurology, cardiology, oncology, and others. The neurology is the largest segment in the global radiopharmaceuticals market. The rising prevalence of neurological disorders is expected to drive the growth of this segment during the forecast period.

Regional Analysis

The Global Radiopharmaceuticals Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas accounted for the largest share in the global radiopharmaceuticals market. The Americas is further segmented into North America and Latin America. North America is further divided into the US and Canada. Latin America consists of Mexico, Brazil, Colombia, Argentina, Chile, Peru, Uruguay, and Venezuela. The rising demand for non-invasive diagnostics and treatments and the presence of a vast patient population suffering from chronic diseases are likely to provide favorable conditions for the growth pf the market.

Europe established substantial growth in the market and anticipated to register the highest CAGR during the forecast period. Europe is segmented into Western Europe, Northern Europe, Eastern Europe, and the Rest of Europe. Rising investment for research and the presence of a vast patient pool and an increasing number of radioisotope approvals for different clinical indications are expected to drive the growth of the market.

The Asia-Pacific market for radiopharmaceuticals is further divided into Japan, China, Australia, India, South Korea, South-East Asia, New Zealand, Pakistan, and the Rest of Asia-Pacific. South-East Asia is further divided into Singapore, Malaysia, Indonesia, Thailand, Vietnam, and the Philippines. The radiopharmaceutical companies are expanding their operations in countries such as China, India, Singapore, and Russia, owing to the cost-efficiency in these regions. Additionally, Asia-Pacific has a large pool of geriatric populations requiring invasive therapies for the treatment of the increasing cases of cardiovascular diseases, neurological diseases, and others. According to the Economic and Social Commission for Asia and the Pacific (ESCAP) in 2016, approximately 12.4% of the population in the region was 60 years or older and is projected to rise to 1.3 billion people by 2050.

The radiopharmaceuticals market in the Middle East & Africa is expected to grow due to the presence of developed countries such as Egypt, Saudi Arabia, and others. Additionally, increasing awareness about radiopharmaceuticals in the region is expected to contribute to the growth of the market.

Access Report Details @  https://www.marketresearchfuture.com/reports/radio-pharmaceutical-market-1650

Key Players

MRFR recognizes the following companies as the Key Players in the Global Radiopharmaceuticals Market— GE Healthcare, Lantheus Medical Imaging, Inc., Novartis AG, BWX Technologies, Inc., Siemens Healthineers, IRE ELiT, JSC Isotope, NTP Radioisotopes SOC Ltd, Curium, Australian Nuclear Science and Technology Organization (ANSTO), and others

TOC:

  1.  Report Prologue    

    2.    Market Introduction   

          2.1    Definition    

          2.2    Scope of the Study    

                2.2.1    Research Objective    

                2.2.2    Assumptions    

                2.2.3    Limitations    

    3.    Research Methodology

          3.1    Introduction

          3.2    Primary Research    

          3.3    Secondary research

          3.4    Market Size Estimation

    TOC…Continued

Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/1650

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Silicon Carbide Wafer Market Growth Opportunity, Size, Status and Forecast To 2026

  IDA Provides Silicon Carbide Wafer Growth Analysis 2021 Report by Key Players, Types, Applications, Countries, and Forecast. The Final Research Insights will get the complete Pandemic Impact Analysis on Information Technology & Telecommunication Category Till 2026: This Silicon Carbide Wafer Market research report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. The global Industry growth depends on several factors that are Rising inclusion of artificial intelligence, automation, internet of things and others are expected to make sure that the market gains good mileage. Involving demand estimation, new product development and entry strategies, marketing and distribution strategies in the high-risk arena of new developments by helping you identify unmet needs. The Silicon Carbide Wafer Market Major Eminent players making significant moves in the global market have earned their ...
Read more

Global eClinical Solutions Market Key Companies, Global Expansion Strategies and Application Scope Till 2023

The  Global eClinical Solutions Market  is estimated to be valued at  USD 9434.57 million by 2023  and is expected to register a  CAGR of 12.24%  during the forecast period . The clinical data management system (CDMS) dominated the  global eClinical solutions market , by type, and is projected to reach  USD 2579 million by 2023  owing to the benefits offered by the product such as centralized end-to-end management of clinical trial activities, real-time status tracking, elimination of reliance on manual processes, and maintenance of multiple databases, which improve the overall efficiency of clinical trials. However, the electronic clinical outcome assessment (eCOA) segment is projected to be the fastest-growing segment during the forecast period. Americas dominated the market, accounting for the largest share of the market in 2017, and the regional market is expected to register a  CAGR of 12.41%  during the review perio...
Read more

Big Data in Healthcare Market Rising Trends, New Designs, Manufacturer Details, Forecasts to 2027

Big Data in Healthcare Market Research Report, by Hardware (Routers, VPNs), by Software (EHR, Practice Management), by Analytical service type (Descriptive, Predictive, Prescriptive) by region (Europe, Americas, APAC & MEA) – Forecast to 2027 The “ Big Data in Healthcare Market  ” In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue. The Big Data in Healthcare Market Free Growth Sample will provide valuable insight with an emphasis on the global market including some of the  major players  such As,  Cerner Corporation, Dell, Mckesson, Philips, Xerox, Cognizant, GE Healthcare,  Optum, Siemens, and others.. For Market Big Data in Healthcare Market analysis, the report covers upstream raw materials, equipment, downstream client survey, Marketing channels, Market development trend and propos...
Read more